GlassScriptPhysician profile
Peter Rothschild
NPI 1790756674
$12,461.29
in general payments reported to CMS, 2019-2025
11 companies · $350 in 2025
The $350 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,356 · 2020: $1,781 · 2021: $1,174 · 2022: $1,050 · 2023: $1,400 · 2024: $350 · 2025: $350.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,100.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $8,682.23 | 2019-2025 | |
| Minerva Surgical, INC | $3,511.22 | 2019-2020 | |
| Therapeuticsmd, INC. | $89.19 | 2019-2021 | |
| Abbvie INC. | $39.58 | 2019 | |
| Millicent US INC | $35.15 | 2019-2020 | |
| Coopersurgical, INC. | $24.56 | 2019-2021 | |
| Organon LLC | $18.51 | 2021 | |
| Merck Sharp & Dohme LLC | $16.60 | 2019 | |
| Hologic Sales and Service, LLC | $16.50 | 2019 | |
| Amag Pharmaceuticals, INC. | $15.86 | 2019 | |
| Exeltis, USA INC. | $11.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Rothschild listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.